Brain activity linked to medication response in OCD
About this title
Read the official source — NCT04131829Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What will I do during this study?
Healthy control participants have one fMRI scan at baseline. Participants with OCD are randomly assigned to start fluoxetine straight away or after a six-week placebo (an inactive comparison treatment) lead-in. They have fMRI scans at baseline and during treatment. The record does not specify the number or length of treatment visits.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 100
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT04131829
- Official title
Show the full official title
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
Recruitment & locations
New Haven
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Fluoxetine - immediate treatment and Fluoxetine - delayed treatment.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
